Expert Opinion on Therapeutic Patents, Volume 34, Issue 3 (2024)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Expert Opinion on Therapeutic Patents, Volume 34, Issue 3 (2024)

See all volumes and issues
Volume 34, 2024 Vol 33, 2023 Vol 32, 2022 Vol 31, 2021 Vol 30, 2020 Vol 29, 2019 Vol 28, 2018 Vol 27, 2017 Vol 26, 2016 Vol 25, 2015 Vol 24, 2014 Vol 23, 2013 Vol 22, 2012 Vol 21, 2011 Vol 20, 2010 Vol 19, 2009 Vol 18, 2008 Vol 17, 2007 Vol 16, 2006 Vol 15, 2005 Vol 14, 2004 Vol 13, 2003 Vol 12, 2002 Vol 11, 2001 Vol 10, 2000 Vol 9, 1999 Vol 8, 1998 Vol 7, 1997 Vol 6, 1996 Vol 5, 1995 Vol 4, 1994 Vol 3, 1993 Vol 2, 1992 Vol 1, 1991
Download citations Download PDFs Download issue

Review

Review Article
Targeting the TGF-β signaling pathway: an updated patent review (2021–present)
Wenhao Guo, Hanwen Liu, Yong Yan, Di Wu, Hequan Yao, Kejiang Lin & Xuanyi Li
Pages: 99-126
Published online: 25 Apr 2024
AbstractforTargeting the TGF-β signaling pathway: an updated patent review (2021–present) | Full Text | References | PDF (2.7 MB) | EPUB
  • 96 Views
  • 0 CrossRef citations
  • 0Altmetric
Review Article
A patent review on HMGB1 inhibitors for the treatment of liver diseases
Richa Raj, Pingping Shen, Boyang Yu & Jian Zhang
Pages: 127-140
Published online: 09 Apr 2024
AbstractforA patent review on HMGB1 inhibitors for the treatment of liver diseases | Full Text | References | PDF (4.1 MB) | EPUB
  • 98 Views
  • 0 CrossRef citations
  • 0Altmetric
Review Article
Targeting the PI3K/AKT signaling pathway in anticancer research: a recent update on inhibitor design and clinical trials (2020–2023)
Dima A. Sabbah, Rima Hajjo, Sanaa K. Bardaweel & Haizhen A. Zhong
Pages: 141-158
Published online: 09 Apr 2024
AbstractforTargeting the PI3K/AKT signaling pathway in anticancer research: a recent update on inhibitor design and clinical trials (2020–2023) | Full Text | References | PDF (3.1 MB) | EPUB
  • 209 Views
  • 0 CrossRef citations
  • 0Altmetric
Review Article
Synthetic lethality: targeting SMARCA2 ATPase in SMARCA4-deficient tumors – a review of patent literature from 2019–30 June 2023
Kyle D. Reichl, Esther C. Y. Lee & Ariamala Gopalsamy
Pages: 159-169
Published online: 05 Apr 2024
AbstractforSynthetic lethality: targeting SMARCA2 ATPase in SMARCA4-deficient tumors – a review of patent literature from 2019–30 June 2023 | Full Text | References | PDF (3.2 MB) | EPUB
  • 260 Views
  • 1 CrossRef citations
  • 0Altmetric
Review Article
An overview on recent patents and technologies on nanoparticles for nucleic acid delivery
Larissa Moraes dos Santos Fonseca, Bruna Aparecida Souza Machado, Fabricia Oliveira Oliveira, Jânio Rodrigo de Jesus Santos, Jaqueline Wang da Silva, Katharine Valeria Saraiva Hodel, Brisa Gonçalves Rosatti, Claudio Damasceno Pinto & Milena Botelho Pereira Soares
Pages: 171-186
Published online: 08 Apr 2024
AbstractforAn overview on recent patents and technologies on nanoparticles for nucleic acid delivery | Full Text | References | PDF (3.9 MB) | EPUB
  • 87 Views
  • 0 CrossRef citations
  • 0Altmetric

Explore articles

Explore the most recently published articles

An updated patent review on PD-1/PD-L1 antagonists (2022-present)
Wiktor Uzar et al.
Review Article | Published online: 21 Jun 2024
Protein tyrosine phosphatase inhibitors: a patent review and update (2012–2023)
Lakshmi Mounika Kelam et al.
Review Article | Published online: 19 Jun 2024
A patent review on hypoxia-inducible factor (HIF) modulators (2021–2023)
Jiaming Liu et al.
Review Article | Published online: 19 Jun 2024
Recent advances in the development of P2Y14R inhibitors: a patent and literature review (2018-present)
Kai Wang et al.
Review Article | Published online: 19 Jun 2024
View all latest articles